Healthcare provider profile · identity verified

Carson Paul Higgs, MD

Family Practice · AUSTIN, TX · NPI 1437304243

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	397	107
Atorvastatin Calcium	Atorvastatin Calcium	352	102
Rosuvastatin Calcium	Rosuvastatin Calcium	342	104
Lisinopril	Lisinopril	255	69
Levothyroxine Sodium	Levothyroxine Sodium	236	63
Metformin Hcl Er	Metformin Hcl	169	51
Omeprazole	Omeprazole	165	46
Ozempic	Semaglutide	158	19
Gabapentin	Gabapentin	144	39
Trazodone Hcl	Trazodone Hcl	136	36
Losartan Potassium	Losartan Potassium	133	35
Zolpidem Tartrate	Zolpidem Tartrate	130	29
Hydrochlorothiazide	Hydrochlorothiazide	106	35
Tamsulosin Hcl	Tamsulosin Hcl	106	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	20
Alprazolam	Alprazolam	103	24
Pravastatin Sodium	Pravastatin Sodium	96	23
Tramadol Hcl	Tramadol Hcl	95	21
Metoprolol Succinate	Metoprolol Succinate	93	28
Alendronate Sodium	Alendronate Sodium	90	27
Bupropion Xl	Bupropion Hcl	87	20
Clonazepam	Clonazepam	73	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	23
Meloxicam	Meloxicam	73	18
Escitalopram Oxalate	Escitalopram Oxalate	67	24
Fluoxetine Hcl	Fluoxetine Hcl	66	18
Metformin Hcl	Metformin Hcl	66	20
Simvastatin	Simvastatin	66	19
Duloxetine Hcl	Duloxetine Hcl	65	15
Montelukast Sodium	Montelukast Sodium	64	19
Mounjaro	Tirzepatide	64	11
Albuterol Sulfate Hfa	Albuterol Sulfate	60	28
Amitriptyline Hcl	Amitriptyline Hcl	60	16
Pantoprazole Sodium	Pantoprazole Sodium	59	17
Jardiance	Empagliflozin	56	suppressed
Allopurinol	Allopurinol	54	17
Diazepam	Diazepam	54	suppressed
Sertraline Hcl	Sertraline Hcl	53	17
Finasteride	Finasteride	50	15
Celecoxib	Celecoxib	49	suppressed
Nebivolol Hcl	Nebivolol Hcl	49	12
Potassium Chloride	Potassium Chloride	49	16
Furosemide	Furosemide	47	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	44	suppressed
Azelastine Hcl	Azelastine Hcl	38	15
Januvia	Sitagliptin Phosphate	38	suppressed
Testosterone Cypionate	Testosterone Cypionate	37	suppressed
Trulicity	Dulaglutide	37	suppressed
Lorazepam	Lorazepam	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	11
Carvedilol	Carvedilol	33	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	11
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Ondansetron Odt	Ondansetron	32	15
Baclofen	Baclofen	31	suppressed
Prednisone	Prednisone	31	18
Atenolol	Atenolol	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	15
Fluticasone Propionate	Fluticasone Propionate	30	11
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Spironolactone	Spironolactone	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Eliquis	Apixaban	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Valsartan	Valsartan	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	16
Gemfibrozil	Gemfibrozil	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Estradiol	Estradiol	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Bupropion Hcl	Bupropion Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Naproxen	Naproxen	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error